OtherArticle
Development of Robust QSAR Models for CYP2C9, CYP2D6, and CYP3A4 Catalysis and Inhibition
Eric Gonzalez, Sankalp Jain, Pranav Shah, Nao Torimoto-Katori, Alexey Zakharov, Ðắc-Trung Nguyễn, Srilatha Sakamuru, Ruili Huang, Menghang Xia, R. Scott Obach, Cornelis E.C.A. Hop, Anton Simeonov and Xin Xu
Drug Metabolism and Disposition June 28, 2021, DMD-AR-2020-000320; DOI: https://doi.org/10.1124/dmd.120.000320
Eric Gonzalez
1Division of Preclinical Innovation, National Center for Advancing Translational Sciences, United States
Sankalp Jain
2Division of Pre-Clinical Innovation, National Center for Advancing Translational Sciences, United States
Pranav Shah
2Division of Pre-Clinical Innovation, National Center for Advancing Translational Sciences, United States
Nao Torimoto-Katori
3Discovery Technology Laboratories, Sohyaku. Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Japan
Alexey Zakharov
2Division of Pre-Clinical Innovation, National Center for Advancing Translational Sciences, United States
Ðắc-Trung Nguyễn
2Division of Pre-Clinical Innovation, National Center for Advancing Translational Sciences, United States
Srilatha Sakamuru
1Division of Preclinical Innovation, National Center for Advancing Translational Sciences, United States
Ruili Huang
1Division of Preclinical Innovation, National Center for Advancing Translational Sciences, United States
Menghang Xia
1Division of Preclinical Innovation, National Center for Advancing Translational Sciences, United States
R. Scott Obach
4Groton Laboratories, Pfizer Global Research and Development, United States
Cornelis E.C.A. Hop
5Genentech, United States
Anton Simeonov
2Division of Pre-Clinical Innovation, National Center for Advancing Translational Sciences, United States
Xin Xu
6NIH, United States
Jump to comment:
No eLetters have been published for this article.
In this issue
OtherArticle
Substrate and Inhibitor QSAR models for CYP2C9, 2D6 and 3A4
Eric Gonzalez, Sankalp Jain, Pranav Shah, Nao Torimoto-Katori, Alexey Zakharov, Ðắc-Trung Nguyễn, Srilatha Sakamuru, Ruili Huang, Menghang Xia, R. Scott Obach, Cornelis E.C.A. Hop, Anton Simeonov and Xin Xu
Drug Metabolism and Disposition June 28, 2021, DMD-AR-2020-000320; DOI: https://doi.org/10.1124/dmd.120.000320
OtherArticle
Substrate and Inhibitor QSAR models for CYP2C9, 2D6 and 3A4
Eric Gonzalez, Sankalp Jain, Pranav Shah, Nao Torimoto-Katori, Alexey Zakharov, Ðắc-Trung Nguyễn, Srilatha Sakamuru, Ruili Huang, Menghang Xia, R. Scott Obach, Cornelis E.C.A. Hop, Anton Simeonov and Xin Xu
Drug Metabolism and Disposition June 28, 2021, DMD-AR-2020-000320; DOI: https://doi.org/10.1124/dmd.120.000320
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement